CAPTRUST Financial Advisors
GMAB icon

CAPTRUST Financial Advisors’s Genmab GMAB Stock Holding History

CAPTRUST Financial Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$685K Sell
25,515
-24,920
-49% -$747K ﹤0.01% 1823
2025
Q4 		$1.55M Buy
50,435
+22,053
+78% +$687K ﹤0.01% 1223
2025
Q3 		$870K Buy
28,382
+5,940
+26% +$145K ﹤0.01% 1510
2025
Q2 		$464K Buy
22,442
+526
+2% +$10.8K ﹤0.01% 1778
2025
Q1 		$429K Sell
21,916
-8,296
-27% -$174K ﹤0.01% 1727
2024
Q4 		$631K Sell
30,212
-2,611
-8% -$57.4K ﹤0.01% 1487
2024
Q3 		$800K Sell
32,823
-12,027
-27% -$322K ﹤0.01% 1320
2024
Q2 		$1.13M Sell
44,850
-1,453
-3% -$41.2K ﹤0.01% 1072
2024
Q1 		$1.38M Buy
46,303
+6,963
+18% +$205K 0.01% 961
2023
Q4 		$1.25M Sell
39,340
-5,025
-11% -$158K ﹤0.01% 1142
2023
Q3 		$1.56M Buy
44,365
+38,797
+697% +$1.48M 0.01% 961
2023
Q2 		$212K Sell
5,568
-520
-9% -$20.7K ﹤0.01% 2220
2023
Q1 		$230K Sell
6,088
-1,303
-18% -$50.1K ﹤0.01% 1960
2022
Q4 		$313K Buy
+7,391
New +$305K ﹤0.01% 1618
2022
Q3 		– Sell
-2,442
Closed -$79K – 2863
2022
Q2 		$79K Sell
2,442
-216
-8% -$7K ﹤0.01% 2387
2022
Q1 		$96K Buy
2,658
+1,017
+62% +$34.9K ﹤0.01% 2302
2021
Q4 		$65K Buy
1,641
+227
+16% +$9.47K ﹤0.01% 2465
2021
Q3 		$62K Buy
1,414
+266
+23% +$11.9K ﹤0.01% 2440
2021
Q2 		$47K Buy
1,148
+90
+9% +$3.47K ﹤0.01% 2548
2021
Q1 		$35K Buy
1,058
+658
+165% +$24.7K ﹤0.01% 2658
2020
Q4 		$16K Hold
400
– – ﹤0.01% 2356
2020
Q3 		$15K Buy
+400
New +$14.5K ﹤0.01% 2105

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

CAPTRUST Financial Advisors's GMAB Position: Q1 2026 in Review

CAPTRUST Financial Advisors reduced its Genmab (GMAB) stake by 49% in Q1 2026, selling an estimated $747K and leaving 25,515 shares worth $685K. The position accounts for ﹤0.01% of the portfolio, ranked #1823.

CAPTRUST Financial Advisors first reported a position in GMAB in Q3 2020 and has held it in 22 quarters since. The position peaked at $1.56M in Q3 2023. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • CAPTRUST Financial Advisors held 25,515 shares of Genmab worth $685K as of Q1 2026.
  • CAPTRUST Financial Advisors sold 24,920 Genmab shares in Q1 2026, an estimated $747K.
  • Genmab made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #1823 holding.
  • CAPTRUST Financial Advisors first reported a position in Genmab in Q3 2020 and has held it in 22 quarters since.
  • CAPTRUST Financial Advisors's Genmab position peaked at $1.56M in Q3 2023.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.